SecBot SecBot
8-K ·Filed Sep 1, 2026

ENOV

Enovis CORP
MIXED
Impact 6/10
Horizonmonths Processed1mo ago SEC0001493152-26-040919
8-K context-dependent: Items 7.01
Actionable Insight ◆ Mixed

Monitor the investor call at 8:30 AM ET today for further details on the strategic rationale and financial outlook. The ~100 bps margin headwind in 2027 is a near-term drag, but the robotics acquisition could strengthen Enovis's competitive position in surgical enabling technology. Watch for any pushback on the deal price or integration risks.

DirectionMixed
Confidencehigh
Horizonmonths
Latest settled — T+20d
ENOV ▼ -10.96% at T+20d
NEUTRAL call -10.96% · α vs SPY -12.14% · entry $20.53 → $18.28
Next anchor: T+60d in 29d
Latest observation: T+37 +6.29% FF3 residual α
Entry = T+0 close
Sep 1, 2026
via day close
T+1d
-1.61%
call -1.61% · α -2.05%
$20.20
settled 8w ago
T+5d
-7.31%
call -7.31% · α -7.39%
$19.03
settled 7w ago
T+20d
-10.96%
call -10.96% · α -12.14%
$18.28
settled 27d ago
T+60d
Pending
in 29d

Price Chart

Loading chart...

Executive Summary

Enovis announced a binding offer to acquire eCential Robotics, a developer of surgical robotics, for an upfront enterprise value of approximately €155 million (€176 million in cash to shareholders) plus up to €35 million in contingent milestones. The deal is expected to close by year-end 2026 and will be funded with cash on hand and its revolving credit facility. Management guided for ~100 bps of adjusted EBITDA margin headwind in 2027, with a return to margin expansion in 2028, and expects free cash flow conversion to increase to 50% (~$100M+) in 2027. The acquisition is a strategic bolt-on to Enovis's enabling technology platform, but the near-term margin dilution and integration risk temper the bullish case.

Key Facts

  • Enovis entered a binding offer to acquire eCential Robotics for an upfront enterprise value of approximately €155 million.
  • Upfront cash consideration to eCential shareholders is approximately €176 million, with up to an additional €35 million in contingent milestone payments.
  • Transaction expected to close by year-end 2026, subject to regulatory approvals.
  • Enovis expects ~150 bps of deal-related dilution to adjusted EBITDA margin in 2027, offset by ~50 bps of underlying improvement, resulting in a ~100 bps headwind.
  • Enovis expects to return to year-over-year margin improvement in 2028.
  • Free cash flow conversion expected to increase to 50% in 2027, to over $100 million.
  • Acquisition funded through cash on hand and existing revolving credit facility.

Financial Impact

Upfront enterprise value of €155M (~$172M) plus up to €35M in earnouts. Guided ~100 bps adjusted EBITDA margin headwind in 2027.

adjusted EBITDA marginfree cash flow conversiondebt

Risk Factors

  • Transaction may not close due to regulatory approvals or works council consultation in France.
  • Integration risks and potential disruption to existing business relationships.
  • Near-term adjusted EBITDA margin dilution of ~100 bps in 2027.
  • Future milestone payments of up to €35M contingent on uncertain achievements.
  • Negative effects on stock price or operating results from the announcement.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-040919
Exhibit: ex99-1.htm0001493152-26-040919
Document: 0001493152-26-040919-index-headers.html0001493152-26-040919
Document: 0001493152-26-040919-index.html0001493152-26-040919
Document: 0001493152-26-040919.txt0001493152-26-040919
9 reports for ENOV
Performance horizon
0% Hit rate @ T+1 0 of 5 directional calls Went positive at some point 2 of 5 best @ T+60▲ +15.30%May 7, 2026
Filters
Rows
Reports for ENOV — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
Institutional Cluster
BEARISH ★ 4/10
$20.81 $21.59▼ −3.75%▼ −4.93%$21.08 (−1.30%)
Sep 8, 2026
6w ago
Insider Cluster
BULLISH ★ 5/10
$19.03 $18.41▼ −3.26%▼ −2.66%$21.08 (+10.77%)
Sep 4, 2026
7w ago
Insider Cluster
BULLISH ★ 5/10
$19.98 $19.03▼ −4.75%▼ −4.29%$21.08 (+5.51%)
Sep 1, 2026
7w ago
8-K
MIXED ★ 6/10
$20.53 $20.20▼ −1.61%▼ −2.05%$21.08 (+2.68%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 1/10
$27.07 $26.84▼ −0.85%▼ −0.69%$21.08 (−22.13%)
May 7, 2026
24w ago
8-K
BULLISH ★ 6/10
$27.25 $26.52▼ −2.68%▼ −3.51%$21.08 (−22.64%)
May 7, 2026
24w ago
Press Release
BULLISH ★ 6/10
$27.25 $26.52▼ −2.68%▼ −3.51%$21.08 (−22.64%)
Apr 10, 2026
28w ago
Press Release
NEUTRAL ★ 1/10
$24.42 $24.86▲ +1.80%▲ +0.83%$21.08 (−13.68%)
Feb 26, 2026
34w ago
8-K
MIXED ★ 7/10
$25.42 $25.47▲ +0.20%▲ +0.65%$21.08 (−17.07%)
Showing 9 of 9

US Market Status

Market Closed — Opens Wed (13h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 1, 2026